Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Reed, C. Curry, S. Rocchio, V. Arnera (Boston, United States Of America). COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin. Eur Respir J 2010; 36: Suppl. 54, 1751

Member's Comments

No comment yet.

Related content which might interest you: COPD severity score and physical activity in Spanish primary care patients: the NEREA study Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 How to value clinical presentation (symptom score, QoL questionnaires) Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 The level of health-related quality of life in patients with COPD and its dependence on age, gender and disease severity Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001 Sex difference and relation with age and asthma duration of average score of quality of life and its components in asthma patients Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation Year: 2008 Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial Source: Eur Respir J 2005; 26: Suppl. 49, 433s Year: 2005 Quality of life, clinical severity and symptom severity in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 142s Year: 2004 Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade? Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC) Source: Eur Respir J 2002; 20: Suppl. 38, 262s Year: 2002 Examination of variations in responder rates in COPD clinical trial outcomes Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Impact of age, age at diagnosis and duration of asthma on the risk of exacerbations in the EuroSMART study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Characteristics of COPD patients with reduced quality of life (QOL) measured with the visual simplified respiratory questionnaire (VSRQ) after 1-year follow-up in the EXACO cohort Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Discordant symptom severity in COPD: The PHAROAH study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Validation of the COPD severity score for use in primary care: the NEREA study Source: Eur Respir J 2009; 33: 519-527 Year: 2009